HCPCS Level II › J
HCPCS Level II codes starting with J
1,255 codes, page 5 of 13. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| J1598 | Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg | Valid |
| J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | Valid |
| J1600 | Injection, gold sodium thiomalate, up to 50 mg | Valid |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Valid |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | Valid |
| J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg | Valid |
| J1612 | Injection, glucagon (gvoke), 0.01 mg | Valid |
| J1620 | Injection, gonadorelin hydrochloride, per 100 mcg through FY2026 | Terminated |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Valid |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | Valid |
| J1628 | Injection, guselkumab, 1 mg | Valid |
| J1630 | Injection, haloperidol, up to 5 mg | Valid |
| J1631 | Injection, haloperidol decanoate, per 50 mg | Valid |
| J1632 | Injection, brexanolone, 1 mg | Valid |
| J1640 | Injection, hemin, 1 mg | Valid |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | Valid |
| J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units | Valid |
| J1644 | Injection, heparin sodium, per 1000 units | Valid |
| J1645 | Injection, dalteparin sodium, per 2500 iu | Valid |
| J1650 | Injection, enoxaparin sodium, 10 mg | Valid |
| J1652 | Injection, fondaparinux sodium, 0.5 mg | Valid |
| J1655 | Injection, tinzaparin sodium, 1000 iu through FY2026 | Terminated |
| J1670 | Injection, tetanus immune globulin, human, up to 250 units | Valid |
| J1675 | Injection, histrelin acetate, 10 micrograms | Valid |
| J1700 | Injection, hydrocortisone acetate, up to 25 mg | Valid |
| J1710 | Injection, hydrocortisone sodium phosphate, up to 50 mg through FY2026 | Terminated |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Valid |
| J1725 | Injection, hydroxyprogesterone caproate, 1 mg through FY2026 | Terminated |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | Valid |
| J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg | Valid |
| J1730 | Injection, diazoxide, up to 300 mg | Valid |
| J1736 | Injection, meloxicam (delova), 1 mg | Valid |
| J1737 | Injection, meloxicam (azurity), 1 mg | Valid |
| J1738 | Injection, meloxicam, 1 mg | Valid |
| J1740 | Injection, ibandronate sodium, 1 mg | Valid |
| J1741 | Injection, ibuprofen, 100 mg | Valid |
| J1742 | Injection, ibutilide fumarate, 1 mg | Valid |
| J1743 | Injection, idursulfase, 1 mg | Valid |
| J1744 | Injection, icatibant, 1 mg | Valid |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Valid |
| J1746 | Injection, ibalizumab-uiyk, 10 mg | Valid |
| J1747 | Injection, spesolimab-sbzo, 1 mg | Valid |
| J1748 | Injection, infliximab-dyyb (zymfentra), 10 mg | Valid |
| J1749 | Injection, iloprost, 0.1 mcg | Valid |
| J1750 | Injection, iron dextran, 50 mg | Valid |
| J1756 | Injection, iron sucrose, 1 mg | Valid |
| J1757 | Injection, tividenofusp alfa-eknm, 1 mg | Valid |
| J1786 | Injection, imiglucerase, 10 units | Valid |
| J1790 | Injection, droperidol, up to 5 mg | Valid |
| J1800 | Injection, propranolol hcl, up to 1 mg | Valid |
| J1805 | Injection, esmolol hydrochloride, 10 mg | Valid |
| J1806 | Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg | Valid |
| J1807 | Injection, ethacrynate sodium, 1 mg | Valid |
| J1808 | Injection, folic acid, 0.1 mg | Valid |
| J1809 | Injection, fosdenopterin, 0.1 mg | Valid |
| J1810 | Injection, droperidol and fentanyl citrate, up to 2 ml ampule through FY2026 | Terminated |
| J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | Valid |
| J1812 | Insulin (fiasp), per 5 units | Valid |
| J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units | Valid |
| J1814 | Insulin (lyumjev), per 5 units | Valid |
| J1815 | Injection, insulin, per 5 units | Valid |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | Valid |
| J1818 | Injection, pegzilarginase-nbln, 0.05 mg | Valid |
| J1823 | Injection, inebilizumab-cdon, 1 mg | Valid |
| J1826 | Injection, interferon beta-1a, 30 mcg | Valid |
| J1830 | Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Valid |
| J1833 | Injection, isavuconazonium, 1 mg | Valid |
| J1834 | Injection, isoniazid, 1 mg | Valid |
| J1835 | Injection, itraconazole, 50 mg | Valid |
| J1836 | Injection, metronidazole, 10 mg | Valid |
| J1837 | Injection, posaconazole, 1 mg | Valid |
| J1840 | Injection, kanamycin sulfate, up to 500 mg through FY2026 | Terminated |
| J1850 | Injection, kanamycin sulfate, up to 75 mg through FY2026 | Terminated |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Valid |
| J1890 | Injection, cephalothin sodium, up to 1 gram through FY2026 | Terminated |
| J1920 | Injection, labetalol hydrochloride, 5 mg | Valid |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | Valid |
| J1930 | Injection, lanreotide, 1 mg | Valid |
| J1931 | Injection, laronidase, 0.1 mg | Valid |
| J1932 | Injection, lanreotide, (cipla), 1 mg | Valid |
| J1938 | Injection, furosemide, 1 mg | Valid |
| J1939 | Injection, bumetanide, 0.5 mg | Valid |
| J1940 | Injection, furosemide, up to 20 mg through FY2026 | Terminated |
| J1941 | Injection, furosemide (furoscix), 20 mg through FY2026 | Terminated |
| J1942 | Injection, aripiprazole lauroxil, 1 mg through FY2026 | Terminated |
| J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg | Valid |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | Valid |
| J1945 | Injection, lepirudin, 50 mg through FY2026 | Terminated |
| J1946 | Injection, furosemide (lasix onyu), 1 mg | Valid |
| J1947 | Injection, furosemide (furoscix), 1 mg | Valid |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | Valid |
| J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg | Valid |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Valid |
| J1953 | Injection, levetiracetam, 10 mg through FY2026 | Terminated |
| J1954 | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg | Valid |
| J1955 | Injection, levocarnitine, per 1 gm | Valid |
| J1956 | Injection, levofloxacin, 250 mg | Valid |
| J1957 | Injection, levetiracetam, 5 mg | Valid |
| J1958 | Injection, levetiracetam in sodium chloride, 5 mg | Valid |
| J1960 | Injection, levorphanol tartrate, up to 2 mg | Valid |